Stock Price
2.11
Daily Change
-3.65%
Yearly
-68.41%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
AbbVie 131.67 -0.31 -0.23% 19.16%
Acadia Pharmaceuticals 21.16 -0.02 -0.09% -60.78%
Acorda Therapeutics 1.79 -0.07 -3.76% -76.45%
Agenus 2.56 -0.12 -4.63% -34.47%
Agios Pharmaceuticals 29.48 -0.32 -1.07% -40.44%
Anika Therapeutics 31.52 -0.47 -1.47% -18.53%
Arrowhead Research 48.66 -2.18 -4.29% -42.16%
AstraZeneca 8,552.00 -200.00 -2.29% 8.29%
Astrazeneca 56.77 -2.33 -3.94% 6.61%
Cerulean Pharma 1.52 -0.07 -4.40% -47.95%
Clovis Oncology 2.11 -0.08 -3.65% -68.41%
Enanta Pharmaceuticals 56.10 -0.39 -0.69% 17.68%
Esperion Therapeutics 3.69 -0.09 -2.38% -85.77%
Five Prime Therapeutics 38.00 0 0% 1,339.39%
GlaxoSmithKline 1,629.40 -17.80 -1.08% 18.06%
GW Pharmaceuticals 218.96 0 0% 108.53%
Halozyme Therapeutics 33.56 -0.33 -0.97% -32.20%
Heron Therapeutics 8.38 -0.15 -1.76% -52.68%
Incyte Corp 75.05 0.26 0.35% -23.33%
Insmed 21.62 -0.38 -1.73% -48.52%
Ligand Pharmaceuticals 114.18 0.50 0.44% -19.94%
Eli Lilly 238.66 -4.40 -1.81% 12.39%
Merck & Co 78.49 -1.49 -1.86% -3.28%
Mirati Therapeutics 113.17 -0.86 -0.75% -47.23%
Neurocrine Biosciences 75.10 2.30 3.16% -35.76%
Novartis 79.87 -1.52 -1.87% -7.05%
Puma Biotechnology 2.35 -0.05 -2.08% -78.90%
Pfizer 51.41 -1.38 -2.61% 37.90%
Ultragenyx Pharmaceutical 66.24 -0.93 -1.38% -52.84%
Rigel Pharmaceuticals 2.36 -0.07 -2.88% -37.07%
Seattle Genetics 127.55 -5.51 -4.14% -30.21%
Sangamo BioSciences 5.68 -0.25 -4.22% -62.01%
Veracyte 25.65 -1.31 -4.86% -53.57%
Acceleron Pharma 178.75 -0.93 -0.52% 57.43%
Intrexon 2.81 -0.15 -5.07% -69.49%

Indexes Price Day Year
NASDAQ 13474 -295.25 -2.14% -1.19%
US2000 1953 -34.83 -1.75% -9.72%

Clovis Oncology
Clovis Oncology, Inc. is a biopharmaceutical company. The Company is focused on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and other international markets. The Company operates through two geographic segments: U.S. and ex-U.S. The Company’s product Rubraca, is an oral small molecule inhibitor of poly ADP-ribose polymerase (PARP), is marketed in the United States for two indications specific to recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer. The Company also provides Lucitanib, which is an investigational, oral, potent angiogenesis inhibitor which inhibits vascular endothelial growth factor receptors one through three (VEGFR1-3), platelet-derived growth factor receptors alpha and beta, and fibroblast growth factor receptors one through three (FGFR1-3). Its other product includes FAP-2286, which is a clinical candidate under investigation as a peptide-targeted radionuclide therapy (PTRT).